A vaccination programme introduced to protect babies and older adults against a dangerous respiratory disease has cut ...

Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...

The respiratory syncytial virus (RSV) vaccine triggered strong immune responses among people aged 60 years and older during ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

MORE than one million people in England are being urged to get a life-saving new vaccine. It protects against respiratory ...

Stephanie Mauro, now 76 years old, has had multiple sclerosis for more than 40 years. In 2020, when COVID-19 first appeared in the United States, her condition had worsened to the point where her ...

High uptake of RSVpreF vaccine and nirsevimab was observed, with 64% of pregnant individuals and 70% of infants receiving ...

Robust immune responses were observed among healthy and high-risk younger adults who received the Ad26/protein RSV preF vaccine.

The NHS has begun inviting older people in Oxfordshire to receive their respiratory syncytial virus (RSV) vaccine.

Respiratory syncytial virus is a common, highly contagious illness that often causes mild upper respiratory symptoms, akin to a cold. In babies, particularly those with tiny airways, RSV can cause the ...

What are the symptoms of RSV and who is eligible for a vaccine? - RSV might at first seem like a cold but it can quickly ...

Local health boards invited adults aged 75–79, including those turning 75 before July 2025, to come forward for their free RSV vaccine ahead of the winter. By the end of November 2024 ...